EAM Investors LLC Cuts Stake in LHC Group, Inc. (LHCG)
EAM Investors LLC reduced its position in LHC Group, Inc. (NASDAQ:LHCG) by 7.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 35,527 shares of the health services provider’s stock after selling 2,709 shares during the quarter. EAM Investors LLC’s holdings in LHC Group were worth $3,659,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of LHCG. BlackRock Inc. boosted its holdings in shares of LHC Group by 76.9% in the 2nd quarter. BlackRock Inc. now owns 4,619,436 shares of the health services provider’s stock worth $395,377,000 after purchasing an additional 2,008,433 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in LHC Group by 74.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 2,133,200 shares of the health services provider’s stock valued at $182,581,000 after acquiring an additional 911,625 shares during the period. FMR LLC boosted its holdings in LHC Group by 297.8% during the 2nd quarter. FMR LLC now owns 1,151,406 shares of the health services provider’s stock valued at $98,548,000 after acquiring an additional 861,952 shares during the period. Bank of New York Mellon Corp boosted its holdings in LHC Group by 162.0% during the 2nd quarter. Bank of New York Mellon Corp now owns 711,508 shares of the health services provider’s stock valued at $60,897,000 after acquiring an additional 439,947 shares during the period. Finally, American Century Companies Inc. purchased a new stake in LHC Group during the 3rd quarter valued at about $35,964,000. Hedge funds and other institutional investors own 86.96% of the company’s stock.
In other LHC Group news, CEO Keith G. Myers sold 75,000 shares of the stock in a transaction that occurred on Tuesday, November 6th. The stock was sold at an average price of $95.10, for a total value of $7,132,500.00. Following the completion of the sale, the chief executive officer now owns 200,765 shares in the company, valued at approximately $19,092,751.50. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, COO Donald Dwayne Stelly sold 2,756 shares of the stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $99.32, for a total value of $273,725.92. Following the completion of the sale, the chief operating officer now owns 104,512 shares of the company’s stock, valued at approximately $10,380,131.84. The disclosure for this sale can be found here. Company insiders own 6.80% of the company’s stock.
NASDAQ LHCG opened at $98.24 on Monday. LHC Group, Inc. has a fifty-two week low of $58.65 and a fifty-two week high of $103.79. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.61 and a quick ratio of 1.61. The company has a market capitalization of $3.08 billion, a price-to-earnings ratio of 40.60, a price-to-earnings-growth ratio of 1.65 and a beta of 0.80.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings data on Wednesday, October 31st. The health services provider reported $0.95 earnings per share for the quarter, hitting the consensus estimate of $0.95. LHC Group had a return on equity of 8.23% and a net margin of 3.85%. The business had revenue of $507.00 million during the quarter, compared to analysts’ expectations of $515.03 million. During the same quarter last year, the business posted $0.64 EPS. The business’s revenue was up 88.0% on a year-over-year basis. As a group, research analysts expect that LHC Group, Inc. will post 3.52 earnings per share for the current year.
LHC Group Company Profile
LHC Group, Inc, a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company operates through four segments: Home Health Services, Hospice Services, Community-Based Services, and Facility-Based Services. The Home Health Services segment offers home nursing services, including wound care and dressing changes, cardiac rehabilitation, infusion therapy, pain management, pharmaceutical administration, skilled observation and assessment, and patient education; medically-oriented social services; and physical, occupational, and speech therapy services.
Further Reading: Trading Strategy
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group, Inc. (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.